drugset / Trial / NCT02124954

A Preliminary Drug Drug Interaction Study With TA-8995

NCT02124954

Phase 1 Completed 18 enrolled Xention Ltd
Non-randomizedSingle-groupOpen-label

Summary

A study in healthy males to look at how multiple doses of TA-8995 affect blood levels and rate of removal of other drugs, using single doses of digoxin and midazolam as examples, to see if there are any potential drug interactions that might affect patients in future studies. The study will examine whether co-administration of TA-8995 affects the pharmacokinetics of digoxin and midazolam measured by area under the curve (AUC).

Timeline

Start
2014-05
Primary completion
2014-07
Completion
2014-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Digoxin Other / unclassified
Subject Midazolam Small molecule
Subject Obicetrapib Small molecule

Indications

No indication recorded.